Almirall Limited

4 The Square, Stockley Park, Uxbridge, UB11 1ET, UK
Telephone: +44 (0) 207 160 2500
Fax: +44 (0) 208 756 3888
WWW: http://www.almirall.com
Medical Information Direct Line: 0800 0087399
Medical Information e-mail: almirall@professionalinformation.co.uk
Customer Care direct line: +44 (0) 207 160 2500
Medical Information Fax: +44 (0) 1748 828 801

Patient Information Leaflet last updated on the eMC: 04/05/2011
PIL Vaniqa 11.5% cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 10/03/2011 and displayed until 04/05/2011
Reasons for adding or updating:
  • Change of licence holder
Updated on 30/11/2009 and displayed until 10/03/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 04/12/2008 and displayed until 30/11/2009
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   eflornithine hydrochloride monohydrate